| UniProt/SwissProt ID: | CCG2_HUMAN |
| Description: | calcium channel, voltage-dependent, gamma subunit 2 [Source:HGNC Symbol;Acc:1406] |
| Location: | chr22 q12.3 |
| Node attribute: | substrate |
| Phosphorylation site |
| Position | PhosphoPeptide | Catalytic kinase | Source |
|---|---|---|---|
| S253 | HSRDAsPVGIK | RegPhos | |
| Y229 | TRIPSyRYRYQ | PhosphoSitePlus | |
| S228 | ITRIPsYRYRY | PhosphoSitePlus | |
| T321 | ANRRTtPV | PKACa | RegPhos |
| T321 | ANRRTt | PRKACA | HPRD |
| S249 | TEPSHsRDASP | PhosphoSitePlus | |
| T321 | ANRRTtPV | RegPhos | |
| Y271 | TEISMyTLSRD | RegPhos | |
| S125 | LCIAAsEFYKT | PMP22_Claudin | PhosphoSitePlus |
| Dephosphorylation site |
| CCG2_HUMAN do not have dephosphorylation site. |
| Mutation site |
| Ensembl ID | Variation | Source | Cancer name | Pubmed |
|---|---|---|---|---|
| ENSP00000300105 | A286T | COSMIC | Skin Cancer | 21984974 |
| ENSP00000300105 | L120H | BIOMART | Pancreatic Cancer | 21930507, 21930502 |
| Differential expressed protein |
| CCG2_HUMAN is not differential expressed protein. |
| Hyperphosphorylation site |
| CCG2_HUMAN do not have hyperphosphorylation site. |
| Direct Interaction Pair |
| Source | Target | Relationship | Resource |
|---|---|---|---|
| ZAGL2_HUMAN | CCG2_HUMAN | kinase -> substrate | RegPhos |
| KPCA_HUMAN | CCG2_HUMAN | kinase -> substrate | HPRD |
| Function Annotation |
| KEGG Pathway |
| KEGG ID | Pathway |
|---|---|
| hsa04260 | Cardiac muscle contraction |
| hsa05412 | Arrhythmogenic right ventricular cardiomyopathy (A |
| hsa05410 | Hypertrophic cardiomyopathy (HCM) |
| hsa04010 | MAPK signaling pathway |
| hsa05414 | Dilated cardiomyopathy |
| Gene Ontology |
| GO ID | GO_Term | Evidence | Ontology |
|---|---|---|---|
| GO:0042391 | regulation of membrane potential | IEA | biological_process |
| GO:0060081 | membrane hyperpolarization | IEA | biological_process |
| GO:0050877 | neurological system process | IEA | biological_process |
| GO:0016020 | membrane | IEA | cellular_component |
| GO:0035255 | ionotropic glutamate receptor binding | IEA | molecular_function |
| GO:0005891 | voltage-gated calcium channel complex | IEA | cellular_component |
| GO:0005245 | voltage-gated calcium channel activity | IEA | molecular_function |
| GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-iso | ISS | biological_process |
| GO:0005515 | protein binding | IPI | molecular_function |
| GO:0007268 | synaptic transmission | TAS | biological_process |
| GO:0006810 | transport | TAS | biological_process |
| GO:0019226 | transmission of nerve impulse | IEA | biological_process |
| GO:0032281 | alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropioni | IEA | cellular_component |
| GO:0051899 | membrane depolarization | IEA | biological_process |
| GO:0030666 | endocytic vesicle membrane | TAS | cellular_component |
| GO:0051899 | membrane depolarization | TAS | biological_process |
| GO:0005515 | protein binding | IEA | molecular_function |
| GO:0007528 | neuromuscular junction development | IEA | biological_process |
| GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-iso | IEA | biological_process |
| GO:0005886 | plasma membrane | TAS | cellular_component |
| GO:0032281 | alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropioni | ISS | cellular_component |